Why Palantir Slide May Be a Setup for a Long-Term Opportunity

Palantir has been in a downtrend since its post-earnings all-time high on Nov. 3 and faces a potential death‑cross if selling continues—the 50‑day SMA (~$180.92) is rolling over, the 100‑day SMA (~$169.88) sits just above the current price (~$166.50), and the 200‑day SMA would be the next major support; declining volume on down days and a rotation out of AI/growth names increase the likelihood of further technical deterioration. The pullback is occurring alongside similar corrections in AI leaders like Nvidia and Supermicro and appears to reflect a market-wide derating and rotation rather than idiosyncratic weakness. Importantly, Palantir’s recurring government and commercial contract growth, a multi‑year uptrend, and historical pattern of 20–30% drawdowns preceding significant rallies argue that the sell‑off could be a digestion phase; tactical dip levels to watch are $160–165 (near the 100‑day SMA) and the 200‑day SMA where institutional buying typically reappears.

Analysis

Palantir has traded lower since its post-earnings all-time high on Nov. 3 and is showing technical weakness that could lead to a death cross if selling persists into late November/early December; the 50-day SMA is rolling over at roughly $180.92, the 100-day SMA has flattened at about $169.88 and sits just above the mid‑day price of $166.50, while the 200-day SMA is the next material support level. Declining volume on down days and a contemporaneous rotation out of AI and other growth names increase the probability of further technical deterioration rather than isolated idiosyncratic selling. Market context supports this being a thematic derating and digestion phase: peers such as NVDA and SMCI are in multi-week corrections despite durable fundamentals, suggesting sentiment and flow changes are driving part of the move. Palantir’s underlying business — recurring government and commercial contracts, a multi‑year uptrend of higher highs and higher lows, and a historical pattern of 20–30% drawdowns followed by significant six‑ to 12‑month recoveries — argues the pullback may be tactical; key tactical levels to watch are the $160–165 support band near the 100-day SMA and the 200-day SMA where institutional buying has historically re‑emerged, though short‑term technical pressure may persist.

Key Decisions for Investors

• Monitor the 50/200-day SMA relationship and trading volume into late November–early December and reduce short-term exposure or hedge if the 50-day moves decisively below the 200-day with confirming downside volume
• Consider staged, size‑limited accumulation in the $160–165 range (near the 100-day SMA and prior August/November support) and plan additional accumulation nearer the 200-day SMA if that level holds, given Palantir’s recurring revenue profile and historical rebound behavior
• Maintain modest position sizing and use stop-losses or option hedges to manage risk from continued AI/growth derating since technical pressure can persist despite durable fundamentals
• Track flows in AI leaders such as NVDA and SMCI and broad sector derating as a thematic risk indicator—worsening breadth would increase downside risk for PLTR